Eye Melanoma Market Research Report- Forecast to 2027

Eye Melanoma Market Research Report: By Site (Sclera, Retina, Uvea), By Diagnosis (Eye Exam, Imaging, Biopsy), Treatment (Radiation Therapy, Laser Treatment, Surgery), End User (Hospitals & Clinics, Academic Institutes) - Global Forecast Till 2027

ID: MRFR/MED/4121-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario:


Melanoma is the cancer of melanin-producing cells. Eye melanoma or ocular melanoma can develop in the middle of the three layers of the eye, i.e., in between the sclera, retina, and uvea. The diseased layers of the eye cannot be visually examined, making the diagnosis of the disease difficult. The sensation of flashing lights, blurry vision in one eye, and loss of peripheral vision are some of the common symptoms of the eye melanoma. Increasing prevalence of the eye cancer and growing geriatric population are the major drivers of the market growth. According to the Cancer Research U.K, approximately 750 new cases of eye cancer were reported on a yearly basis within the U.K from 2013-2015.


Moreover, it was estimated that from the last decade, the prevalence of eye cancer has increased by 25% in the U.K. Additionally, rising healthcare expenditures and increasing research and development investments by the major players of the market boosts the market growth. However, lack of awareness, high diagnostics, and surgical procedures costs are estimated to restrain the market growth during the forecast period. The cost of the therapeutic procedures like laser iridotomy is estimated to be around USD 1,068 to USD 1,188. This makes such procedures an out of pocket concern for many patients.


Global Eye Melanoma Market is expected to grow at an approximate CAGR of 7.8% during the forecast period.


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and Private Laboratories

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers


Figure 1: Global Eye Melanoma Market Share, By Region
Eye Melanoma Market


Sources: American Cancer Society, WHO, Mayo Foundation for Medical Education and Research, American Society of Clinical Oncology, Office for National Statistics, annual reports, press release, white paper, and company presentation


Segmentation


The global eye melanoma market is segmented on the basis of the site, diagnosis, treatment, and end user.


On the basis of the site, the market is segmented into sclera, retina, uvea, and others.


On the basis of the diagnosis, the market is categorized into eye exam, imaging, biopsy, and others. The eye exam segment is further categorized into ophthalmoscopy, slit-lamp biomicroscopy, and others. The imaging is sub-segmented into ultrasound, fluorescein angiography, fundus autofluorescence, optical coherence tomography, and others. On the basis of the treatment, the market is segmented into radiation therapy, laser treatment, surgery, and others. The radiation therapy segment is sub-segmented into episcleral plaque therapy, external beam radiation therapy, and others. The external beam radiation therapy is further segmented into conformal proton beam radiation therapy, stereotactic radiosurgery, and others. The surgery segment is sub-segmented into iridectomy, choroidectomy, enucleation, and others. On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, and others.


Regional Analysis


America dominates the global eye melanoma market owing to the presence of a well-developed healthcare sector and huge patient population. Apart from this, increasing number of patients, changing lifestyle, and increasing healthcare expenditure have boosted the growth of the American market. Additionally, the presence of the major market players like the GENERAL ELECTRIC, Analogic Corporation, NOVADAQ Technologies Inc. within the region fuels the market growth.


Europe is the second largest eye melanoma market. Factors such as increasing availability of funds for research, well-developed healthcare sector, huge patient population, and growing geriatric population are estimated to drive the market growth within the region. According to the Office for National Statistics the geriatric population within the U.K is estimated to reach approximately 69.8 billion by 2026 from 65.6 billion in 2016. 


The Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies and rising healthcare expenditure. In countries like India, the presence of huge opportunities along with favorable government policies fuels the market growth.


The Middle East & Africa has the least share in the global eye melanoma market due to the presence of poor economies and stringent government policies, especially in the Africa region. The Middle East holds a majority of the market due to a well-developed healthcare sector and huge healthcare expenditure by economies like Dubai, Kuwait, Dubai, and others.


Research Methodology
Research Methodology 1


Sources: American Cancer Society, WHO, Mayo Foundation for Medical Education and Research, American Society of Clinical Oncology, Office for National Statistics, annual reports, press release, white paper, and company presentation


Key players in global eye melanoma market


The key players for the global eye melanoma market are Castle Biosciences, Inc. (U.S.), GENERAL ELECTRIC (U.S.), Koninklijke Philips N.V. (The Netherlands), TOSHIBA CORPORATION (Japan), Siemens AG (Germany), Analogic Corporation (U.S.), Optovue, Incorporated (U.S.), NOVADAQ Technologies Inc. (Canada), Agfa-Gevaert Group (Belgium), and ZEISS (Germany).



TABLE OF CONTENT


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Eye Melanoma Market, By Site

6.1 Introduction

6.2 Sclera

Market Estimates & Forecast, 2020 – 2027

6.3 Retina

Market Estimates & Forecast, 2020 – 2027

6.4 Uvea

Market Estimates & Forecast, 2020 – 2027

Chapter 7. Global Eye Melanoma Market, By Diagnosis

7.1 Introduction

7.2 Eye Exam

Market Estimates & Forecast, 2020 – 2027

7.2.1 Ophthalmoscopy

7.2.2 Slit-Lamp Biomicroscopy

7.2.3 Others

7.3 Imaging

Market Estimates & Forecast, 2020 – 2027

7.3.1 Ultrasound

7.3.2 Fluorescein Angiography

7.3.3 Fundus Autofluorescence

7.3.4 Optical Coherence Tomography

7.3.5 Others

7.4 Biopsy

Market Estimates & Forecast, 2020 – 2027

7.5 Others

Chapter 8. Global Eye Melanoma Market, By Treatment

8.1 Introduction

8.2 Radiation Therapy

Market Estimates & Forecast, 2020 – 2027

8.2.1 Episcleral Plaque Therapy

8.2.2 External Beam Radiation Therapy

8.2.2.1 Computed Tomography (CT)

8.2.2.2 Positron Emission Tomography (PET)

8.2.2.3 Others

8.3 Laser Treatment

Market Estimates & Forecast, 2020 – 2027

8.4 Surgery

Market Estimates & Forecast, 2020 – 2027

8.4.1 Iridectomy

8.4.2 Choroidectomy

8.4.3 Enucleation

8.4.4 Others

Chapter 9 Global Eye Melanoma Market, By End User

9.1 Introduction

9.2 Hospitals & Clinics

Market Estimates & Forecast, 2020 – 2027

9.3 Academic Institutes

Market Estimates & Forecast, 2020 – 2027

9.4 Others

Chapter 10. Global Eye Melanoma Market, By Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K

10.3.1.6 Rest Of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic Of Korea

10.4.6 Rest Of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest Of The Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Castle Biosciences, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 GENERAL ELECTRIC

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Koninklijke Philips N.V.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 TOSHIBA CORPORATION

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Siemens AG

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Analogic Corporation

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Optovue, Incorporated

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 NOVADAQ Technologies Inc.

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Agfa-Gevaert Group

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 ZEISS

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs Of The Market

13.2 Key Companies To Watch

13.3 Prediction Of Pharmaceutical Industry

Chapter 14 Appendix


LIST OF TABLES

Table 1 Eye Melanoma Industry Synopsis, 2020 – 2027

Table 2 Global Eye Melanoma Market Estimates And Forecast, 2020 – 2027, (USD Million)

Table 3 Global Eye Melanoma Market By Region, 2020 – 2027, (USD Million)

Table 4 Global Eye Melanoma Market By Site, 2020 – 2027, (USD Million)

Table 5 Global Eye Melanoma Market By Diagnosis, 2020 – 2027, (USD Million)

Table 6 Global Eye Melanoma Market By Treatment, 2020 – 2027, (USD Million)

Table 7 Global Eye Melanoma Market By End User, 2020 – 2027, (USD Million)

Table 8 North America Eye Melanoma Market By Site, 2020 – 2027, (USD Million)

Table 9 North America Eye Melanoma Market By Diagnosis, 2020 – 2027, (USD Million)

Table 10 North America Eye Melanoma Market By Treatment, 2020 – 2027, (USD Million)

Table 11 North America Eye Melanoma Market By End User, 2020 – 2027, (USD Million)

Table 12 US Eye Melanoma Market By Site, 2020 – 2027, (USD Million)

Table 13 US Eye Melanoma Market By Diagnosis, 2020 – 2027, (USD Million)

Table 14 US Eye Melanoma Market By Treatment, 2020 – 2027, (USD Million)

Table 15 US Eye Melanoma Market By End User, 2020 – 2027, (USD Million)

Table 16 Canada Eye Melanoma Market By Site, 2020 – 2027, (USD Million)

Table 17 Canada Eye Melanoma Market By Diagnosis, 2020 – 2027, (USD Million)

Table 18 Canada Eye Melanoma Market By Treatment, 2020 – 2027, (USD Million)

Table 19 Canada Eye Melanoma Market By End User, 2020 – 2027, (USD Million)

Table 20 South America Eye Melanoma Market By Site, 2020 – 2027, (USD Million)

Table 21 South America Eye Melanoma Market By Diagnosis, 2020 – 2027, (USD Million)

Table 22 South America Eye Melanoma Market By Treatment, 2020 – 2027, (USD Million)

Table 23 South America Eye Melanoma Market By End User, 2020 – 2027, (USD Million)

Table 24 Europe Eye Melanoma Market By Site, 2020 – 2027, (USD Million)

Table 25 Europe Eye Melanoma Market By Diagnosis, 2020 – 2027, (USD Million)

Table 26 Europe Eye Melanoma Market By Treatment, 2020 – 2027, (USD Million)

Table 27 Europe Eye Melanoma Market By End User, 2020 – 2027, (USD Million)

Table 28 Western Eye Melanoma Europe Market By Site, 2020 – 2027, (USD Million)

Table 29 Western Europe Eye Melanoma Market By Diagnosis, 2020 – 2027, (USD Million)

Table 30 Western Europe Eye Melanoma Market By Treatment, 2020 – 2027, (USD Million)

Table 31 Western Europe Eye Melanoma Market By End User, 2020 – 2027, (USD Million)

Table 32 Eastern Europe Eye Melanoma Market By Site, 2020 – 2027, (USD Million)

Table 33 Eastern Europe Eye Melanoma Market By Diagnosis, 2020 – 2027, (USD Million)

Table 34 Eastern Europe Eye Melanoma Market By Treatment, 2020 – 2027, (USD Million)

Table 35 Eastern Europe Eye Melanoma Market By End User, 2020 – 2027, (USD Million)

Table 36 Asia Pacific Eye Melanoma Market By Site, 2020 – 2027, (USD Million)

Table 37 Asia Pacific Eye Melanoma Market By Diagnosis, 2020 – 2027, (USD Million)

Table 38 Asia Pacific Eye Melanoma Market By Treatment, 2020 – 2027, (USD Million)

Table 39 Asia Pacific Eye Melanoma Market By End User, 2020 – 2027, (USD Million)

Table 40 Middle East & Africa Eye Melanoma Market By Site, 2020 – 2027, (USD Million)

Table 41 Middle East & Africa Eye Melanoma Market By Diagnosis, 2020 – 2027, (USD Million)

Table 42 Middle East & Africa Eye Melanoma Market By Treatment, 2020 – 2027, (USD Million)

Table 43 Middle East & Africa Eye Melanoma Market By End User, 2020 – 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Eye Melanoma Market

Figure 3 Segmentation Market Dynamics For Global Eye Melanoma Market

Figure 4 Global Eye Melanoma Market Share, By Site 2020

Figure 5 Global Eye Melanoma Market Share, By Diagnosis 2020

Figure 6 Global Eye Melanoma Market Share, By Treatment 2020

Figure 7 Global Eye Melanoma Market Share, By End User, 2020

Figure 8 Global Eye Melanoma Market Share, By Region, 2020

Figure 9 North America Eye Melanoma Market Share, By Country, 2020

Figure 10 Europe Eye Melanoma Market Share, By Country, 2020

Figure 11 Asia Pacific Eye Melanoma Market Share, By Country, 2020

Figure 12 Middle East & Africa Eye Melanoma Market Share, By Country, 2020

Figure 13 Global Eye Melanoma Market: Company Share Analysis, 2020 (%)

Figure 14 Castle Biosciences, Inc.: Key Financials

Figure 15 Castle Biosciences, Inc.: Segmental Revenue

Figure 16 Castle Biosciences, Inc.: Geographical Revenue

Figure 17 GENERAL ELECTRIC: Key Financials

Figure 18 GENERAL ELECTRIC: Segmental Revenue

Figure 19 GENERAL ELECTRIC: Geographical Revenue

Figure 20 Koninklijke Philips N.V.: Key Financials

Figure 21 Koninklijke Philips N.V.: Segmental Revenue

Figure 22 Koninklijke Philips N.V.: Geographical Revenue

Figure 23 TOSHIBA CORPORATION: Key Financials

Figure 24 TOSHIBA CORPORATION: Segmental Revenue

Figure 25 TOSHIBA CORPORATION: Geographical Revenue

Figure 26 Siemens AG: Key Financials

Figure 27 Siemens AG: Segmental Revenue

Figure 28 Siemens AG: Geographical Revenue

Figure 29 Analogic Corporation:Key Financials

Figure 30 Analogic Corporation: Segmental Revenue

Figure 31 Analogic Corporation: Geographical Revenue

Figure 32 Optovue, Incorporated: Key Financials

Figure 33 Optovue, Incorporated: Segmental Revenue

Figure 34 Optovue, Incorporated: Geographical Revenue

Figure 35 NOVADAQ Technologies Inc.: Key Financials

Figure 36 NOVADAQ Technologies Inc.: Segmental Revenue

Figure 37 NOVADAQ Technologies Inc.: Geographical Revenue

Figure 38 Agfa-Gevaert Group: Key Financials

Figure 39 Agfa-Gevaert Group: Segmental Revenue

Figure 40 Agfa-Gevaert Group: Geographical Revenue

Figure 41 ZEISS: Key Financials

Figure 42 ZEISS: Segmental Revenue

Figure 43 ZEISS: Geographical Revenue

Bottom of Form